Heparin. New Biochemical and Medical Aspects : Proceedings of the Symposium of the Deutsche Gesellschaft Für Klinische Chemie, Titisee, Breisgau, Germany June 29th–July 1st, 1981

Dieser Titel aus dem De Gruyter-Verlagsarchiv ist digitalisiert worden, um ihn der wissenschaftlichen Forschung zugänglich zu machen. Da der Titel erstmals im Nationalsozialismus publiziert wurde, ist er in besonderem Maße in seinem historischen Kontext zu betrachten. Mehr erfahren Sie. > Preface Introductory Welcome List Of Participants Contents I. Heparin: Structure, Mechanism of Action, Biosynthesis and Catabolism The Function and Structure of the Heparin Molecule Biosynthesis of Heparin Physiological Heparin - its Function and Fate Mechanism of Heparin Rebound and Heparin-Protamine Interactions II. Methods for the Determination of Heparin Overview on Methods for the Determination of Heparin Control of Heparin Therapy by Measurement of the Antithrombin III-Heparin-Complex Determination of Heparin by a Fluorogenic Synthetic Substrate Properties of the Coatest ® Heparin As say A Sensitive Competitive Binding Assay for Heparin Determination of Low Dose Heparin Activities in Plasma Characterization of Heparin Preparations in Vivo by Different Test Systems Determination of Heparin and Fractionated Heparin with Different Molecular Weights III. Clinical Usage of Heparin Low Molecular Weight Heparin and the Prevention of Postoperative Deep Vein Thrombosis The Effect of Heparins on Platelet Release Reaction Characterization of a New Potent Heparin Side Effects of Heparin Role of Heparin-Like Molecules in Atherogenesis Unresolved Problems in the Use of Heparin IV. Experience with "Monitoring of Heparin Therapy" Heparin Treatment of Deep Venous Thrombosis: Correlation Between Clinical Effects and Heparin Assays Heparin-, Heparin Cofactor- and Platelet Factor 4 Plasma Levels Under Heparin Treatment Determination of Heparin, Partial Thromboplastin Time and Antithrombin III after Subcutaneous Heparin Administration Monitoring of Heparin During Extracorporal Circulation in Open Heart Surgery Chromogenic and Fluorogenic Assays - A Challenge for Conventional Monitoring of Heparin Therapy? V. Concluding Discussion Introduction Subject Index